The DRE Matrix — Understanding Drug Symptom Recognition Across Seven Substance Categories
When a Drug Recognition Expert needs to determine whether someone may be impaired — and which type of substance might be responsible — they rely on a structured reference framework built around observable physical and behavioral signs. That framework is the dre matrix. Organized around seven major drug categories, it maps specific physiological changes and behavioral symptoms to each class of substance, giving evaluators a consistent, evidence-based foundation for their assessments. If you want to work directly from the source, you can consult the full Drug Symptom Matrix reference document to see how all of this data is laid out in its original form. This article breaks that information down into plain language — covering what the matrix includes, how each drug category behaves differently in the body, and why these distinctions matter.
What Is the DRE Drug Matrix?
The dre drug matrix is a standardized comparison tool used in Drug Recognition Expert (DRE) evaluations — a formal protocol in which specially trained officers assess whether an individual is impaired by drugs and, if so, which category of drug is likely involved. Rather than relying on a single clue, the DRE approach looks at a combination of physiological signs, eye behavior, and observable conduct that together form a recognizable pattern.
This same framework also forms the backbone of the aride drug matrix, used in the ARIDE program — Advanced Roadside Impaired Driving Enforcement. The aride matrix applies an identical seven-category structure and the same physiological indicators, making it a consistent foundation across both entry-level and advanced impairment training. Both programs depend on the same underlying science: that different classes of substances produce measurably different effects on the body.
The Seven Drug Categories in the Drug Category Matrix
The drug category matrix is built around seven distinct substance groups. Each has its own recognized pattern of symptoms that distinguishes it from the others. These are the matrix drugs covered by the framework:
- CNS Depressants — substances that slow central nervous system activity, including alcohol, benzodiazepines, and sedatives such as Quaaludes
- Inhalants — volatile substances breathed in for their intoxicating effects, including aerosols, solvents, and anesthetic gases
- PCP (Phencyclidine) — a dissociative drug that combines stimulant, depressant, and hallucinogenic properties
- Cannabis — marijuana and other THC-containing products
- CNS Stimulants — substances that accelerate central nervous system activity, such as amphetamines and cocaine
- Hallucinogens — substances that distort perception and sensory experience, including LSD and psilocybin
- Narcotic Analgesics — opioids and related pain-relief substances, including heroin and prescription opiates
No two categories produce the same combination of signs — which is the core value of this tool. Understanding which matrix drug belongs to which category is what allows trained evaluators to make meaningful distinctions even without toxicology results on hand.
Key Physiological Signs: The DRE Chart in Detail
The centerpiece of the drug matrix chart is its systematic comparison of measurable physiological responses across all seven drug categories. The table below reflects the documented values from the source matrix for eight key indicators:
| Indicator | CNS Depressants | Inhalants | PCP | Cannabis | CNS Stimulants | Hallucinogens | Narcotic Analgesics |
|---|---|---|---|---|---|---|---|
| HGN (Horizontal Gaze Nystagmus) | Present | Present | Present | None | None | None | None |
| Vertical Nystagmus | Present (High Dose) | Present (High Dose) | Present | None | None | None | None |
| Lack of Convergence | Present | Present | Present | Present | None | None | None |
| Pupil Size | Normal | Normal | Normal | Dilated | Dilated | Dilated | Constricted |
| Reaction to Light | Slow | Slow | Normal | Normal | Slow | Normal | Little to none visible |
| Pulse Rate | Down | Up | Up | Up | Up | Up | Down |
| Blood Pressure | Down | Up/Down | Up | Up | Up | Up | Down |
| Body Temperature | Normal | Up/Down/Normal | Up | Normal | Up | Up | Down |
Several documented exceptions and clarifications accompany this data:
- Within CNS Depressants, Soma and Quaaludes usually dilate pupils — an exception to the otherwise normal pupil size for this category. Quaaludes and alcohol (ETOH) may also elevate pulse rate, which normally goes down.
- For Inhalants, pupil size is generally normal but may be dilated depending on the substance. Blood pressure direction also depends on the specific substance: it goes down with anesthetic gases but up with volatile solvents and aerosols.
- Vertical nystagmus in CNS Depressants and Inhalants appears only at a high dose for that particular individual.
- For Hallucinogens, the reaction to light is generally normal — however, certain psychedelic amphetamines within this category may cause a slowing response.
- Cannabis pupils are listed as dilated, though the source notes that pupil size may sometimes appear normal.
- With Narcotic Analgesics, the pupillary light reaction is so suppressed it is described as “little to none visible.”
Behavioral and Physical Indicators by Drug Category
Beyond vital signs, the drug matrix documents a detailed set of observable behavioral and physical indicators for each category. Here is what the matrix records for each one.
CNS Depressants
- Drunk-like behavior and gait ataxia (impaired walking)
- Thick, slurred speech and general disorientation
- Uncoordinated movements and fumbling
- Drowsiness and droopy eyes
Inhalants
- Residue of the substance around the nose and mouth
- Odor of the substance present on the person
- Bloodshot, watery eyes and flushed face
- Lack of muscle control and slurred speech
- Intense headaches and possible nausea
- Non-communicative behavior and confusion
PCP
- Blank stare and warm, perspiring skin
- Difficulty speaking, with incomplete and repetitive verbal responses
- Markedly increased pain threshold and cyclic behavior
- Possible violent or combative behavior
- A distinctive “Moon Walking” gait pattern
- Chemical odor
Cannabis
- Very red eyes and odor of marijuana
- Body tremors and eyelid tremors
- Relaxed inhibitions and increased appetite
- Impaired perception of time and distance
- Possible paranoia and disorientation
CNS Stimulants
- Excited, euphoric, and unusually talkative behavior
- Restlessness, body tremors, and exaggerated reflexes
- Bruxism (teeth grinding) and dry mouth
- Redness around the nasal area and runny nose
- Increased alertness alongside insomnia and loss of appetite
- Anxiety and irritability
Hallucinogens
- Dazed appearance and body tremors
- Hallucinations, paranoia, and synesthesia (a blending of the senses)
- Poor perception of time and distance
- Nausea, perspiring, and memory loss
- Disorientation and possible flashbacks
- With LSD specifically, piloerection (goosebumps) may be observed
Narcotic Analgesics
- Droopy eyelids (ptosis) and an “on the nod” drowsy appearance
- Depressed reflexes and low, raspy, slow speech
- Dry mouth and facial itching
- Euphoria and nausea
- Fresh puncture marks or track marks if the substance was injected
- Users who have developed a tolerance may show relatively little psychomotor impairment
How Long Do Effects Last?
Duration of impairment varies considerably across drug categories. One matrix drug might produce noticeable effects that fade within minutes, while another can keep someone impaired for most of a day. The following table documents the effect durations recorded in the source matrix:
| Drug Category | Duration of Effects |
|---|---|
| CNS Depressants | 1–16 hours (depending on the substance) |
| Inhalants | 5 minutes to 8 hours (depending on the substance) |
| PCP | 4–6 hours |
| Cannabis | 2–3 hours |
| CNS Stimulants | 4–24 hours (depending on the substance) |
| Hallucinogens | Varies depending on type of hallucinogen |
| Narcotic Analgesics | 5 minutes to 12 hours (depending on the substance) |
The wide ranges within several categories highlight why the specific substance matters — two drugs within the same category can have dramatically different timelines of impairment.
Methods of Administration
The dre symptomatology matrix also documents common routes of administration for each category. This information plays a supporting role in evaluations, since visible signs such as injection marks, residue around the nose and mouth, or a distinctive odor on clothing can point toward a specific method — and by extension, toward specific substances.
- CNS Depressants: Oral, injected, insufflated, smoked
- Inhalants: Insufflated, injected, eye drops
- PCP: Smoked, oral, insufflated, injected
- Cannabis: Smoked, oral
- CNS Stimulants: Oral, insufflated, smoked, injected, transdermal
- Hallucinogens: Oral, injected, smoked, insufflated
- Narcotic Analgesics: Oral, injected, smoked, insufflated
Overdose Warning Signs
The matrix also records overdose indicators for each drug category — critical information in emergency situations where rapid identification of the substance type can inform how first responders act.
| Drug Category | Overdose Warning Signs |
|---|---|
| CNS Depressants | Slow, shallow breathing; clammy skin; coma; convulsions |
| Inhalants | Shallow breathing; cold, clammy skin; dilated pupils; rapid, weak pulse; coma |
| PCP | Coma; long, intense trip; fatigue; paranoia; agitation |
| CNS Stimulants | Increased body temperature; hallucinations; convulsions; long, intense trip |
Why the Drug Matrix Matters
Whether it is referenced in the field as a printed dre chart, built into a training curriculum as an imatrix drug evaluation guide, or studied as part of a broader impairment assessment program, the drug matrix provides something genuinely valuable: a shared, systematic language for describing how substances affect the human body in observable ways.
The power of the framework lies in what it reveals through contrast. CNS Depressants and Narcotic Analgesics both slow down the body and drop the pulse — but narcotics constrict the pupils to the point where they barely respond to light, while depressants leave pupil size essentially normal. PCP and Cannabis both elevate blood pressure and pulse — but PCP can make someone alarmingly combative and raise body temperature, while Cannabis tends toward paranoia and red eyes without the same aggression or temperature spike. These distinctions matter enormously, both in law enforcement contexts and in emergency medical response.
Understanding the drug matrix is relevant not just for professionals in the field. For anyone interested in public health, road safety, workplace drug policy, or the pharmacology of impairment, this framework offers a clear and practical window into how different substances leave their mark on the body — and how trained observers learn to read those marks with consistency and purpose.